Abpro Bio Co., Ltd. announced a private placement of 4,587,155 shares at the price of KRW 1,090 per share for gross proceeds of KRW 4,999,998,950 on October 14, 2021. The transaction will include participation from Wonjin Partners Co., Ltd. The shares will have restriction for 1 years. The face value of shares is KRW 500 per share. The method of issuance is third party allotment method. The board of directors of the company has approved the transaction. The transaction is expected to close on December 29, 2021.